Panacos Pharmaceuticals, Inc.

Patents = 4

Forward Citations = 29

where 'Filed Patents' based on already Granted Patents

where 'Inventors Filed' based on already Granted Patents

17 inventors (with patents filed for the assignee):

Panacos Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to developing innovative antiviral therapeutics for the treatment of HIV/AIDS. The company's lead product candidate, bevirimat, is a novel HIV maturation inhibitor that holds promise as a potential new treatment option for individuals living with HIV. Panacos is committed to advancing the field of antiviral drug development and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com